The Delta Dental Community Care Foundation recently gave a $131,483 grant to San Ysidro Health to upgrade dental work spaces and for an X-ray system.
Todd Young, the chief financial officer of Acadia Pharmaceuticals, recently joined another company.
DEVICES: Region Also Has Strong Exec Bullpen, Partnership Possibilities
About a decade ago, Dexcom executives explored a wild idea: a constant reading of glucose levels beamed to a smartphone.
San Diego-based NuVasive recently tapped a new CEO, a move analysts say looks to bring fresh perspective to an expanding company that’s nonetheless stumbled on execution and has been an acquisition target.
San Diego medical device company ResMed posted revenue of $588.3 million in quarter one results, a 12 percent year-over-year increase.
This year's Quick Pitch competition broke records for funding and attendance as 10 finalists competed for $75,000 in prize money.
KidneyX, a $2.65 million accelerator program, announced its launch in San Diego to find better treatments for kidney disease.
Patient technical care workers and other union employees across the state, including in San Diego, on Tuesday started a three-day walkout aimed at UC Medical Centers.
Illumina reported adjusted quarter three earnings per share of $1.52, or $0.26 better than analysts’ expectation.
Qpex Biopharma, in the business of antibiotics to combat antimicrobial resistance, surfaced Oct. 22 with a $33 million Series A round and a contract worth up to $132 million.
UC San Diego Health said it received a $25 million pledge from the Wertheim Family Foundation to fund a public health initiative at the university.
NuVasive CEO Gregory Lucier will step down, and the company will bring in his successor from Medtronic.
The partnership allowed the San Diego County Credit Union Holiday Bowl, which is hosting the event, to enhance the marketing efforts for the college football game in hopes of drawing a record number in attendees.
The funding will go towards research, led by LJI professor Stephen Schoenberger to improve immunotherapeutic treatment for patients with head and neck cancer.
San Diego startup Stratify Genomics wants to improve testing for prostate cancer by screening individuals to determine who is at a higher risk of developing it.